CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: Implications for adjuvant activity and antibody production
- 30 November 2007
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 125 (2), 138-148
- https://doi.org/10.1016/j.clim.2007.07.006
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Immunostimulatory monoclonal antibodies for cancer therapyNature Reviews Cancer, 2007
- Pyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases, and nuclear factor-κBAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent mannerEuropean Journal of Immunology, 2004
- Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activitiesEuropean Journal of Immunology, 2003
- The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cellsBlood, 2003
- A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cellsBlood, 2003
- Host Response to Infection: the Role of CpG DNA in Induction of Cyclooxygenase 2 and Nitric Oxide Synthase 2 in Murine MacrophagesInfection and Immunity, 2001
- Adjuvant effects of CpG oligodeoxynucleotides on responses against T‐independent type 2 antigensImmunology, 2001
- Regulation of Immunoglobulin G2 Production by Prostaglandin E2and Platelet-Activating FactorInfection and Immunity, 2000
- Negative selection of human germinal center B cells by prolonged BCR cross-linking.The Journal of Experimental Medicine, 1996